Royal Bank of Canada
FTXH icon

Royal Bank of Canada’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Royal Bank of Canada’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2K Buy
+50
New +$1.71K ﹤0.01% 6699
2024
Q4 		– Sell
-6,402
Closed -$185K – 7005
2024
Q3 		$185K Sell
6,402
-18,731
-75% -$536K ﹤0.01% 4873
2024
Q2 		$685K Buy
25,133
+20,907
+495% +$560K ﹤0.01% 3766
2024
Q1 		$118K Sell
4,226
-17,905
-81% -$493K ﹤0.01% 5089
2023
Q4 		$589K Sell
22,131
-24
-0.1% -$605 ﹤0.01% 4131
2023
Q3 		$566K Buy
22,155
+12,447
+128% +$329K ﹤0.01% 3939
2023
Q2 		$254K Buy
9,708
+530
+6% +$14K ﹤0.01% 4534
2023
Q1 		$240K Sell
9,178
-7,695
-46% -$206K ﹤0.01% 4466
2022
Q4 		$463K Sell
16,873
-25,543
-60% -$680K ﹤0.01% 4179
2022
Q3 		$1.02M Buy
+42,416
New +$1.1M ﹤0.01% 3439
2020
Q1 		– Sell
-400
Closed -$9K – 6779
2019
Q4 		$9K Hold
400
– – ﹤0.01% 6183
2019
Q3 		$8K Hold
400
– – ﹤0.01% 5843
2019
Q2 		$8K Sell
400
-2,600
-87% -$54K ﹤0.01% 6101
2019
Q1 		$64K Sell
3,000
-557
-16% -$11.6K ﹤0.01% 5038
2018
Q4 		$68K Hold
3,557
– – ﹤0.01% 4936
2018
Q3 		$84K Buy
3,557
+2,600
+272% +$60.3K ﹤0.01% 4950
2018
Q2 		$21K Buy
957
+400
+72% +$8.51K ﹤0.01% 5511
2018
Q1 		$12K Hold
557
– – ﹤0.01% 5646
2017
Q4 		$12K Hold
557
– – ﹤0.01% 5795
2017
Q3 		$11K Hold
557
– – ﹤0.01% 6228
2017
Q2 		$12K Hold
557
– – ﹤0.01% 5729
2017
Q1 		$11K Sell
557
-551
-50% -$10.7K ﹤0.01% 5923
2016
Q4 		$20K Buy
+1,108
New +$20.8K ﹤0.01% 5758

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
MIM
Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

Royal Bank of Canada's FTXH Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q1 2026: 50 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #6699 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in FTXH as recently as Q3 2024.

Royal Bank of Canada first reported a position in FTXH in Q4 2016 and has held it in 23 quarters since. The position peaked at $1.02M in Q3 2022. 32 funds tracked by Wall St. Rank hold FTXH as of Q1 2026.

  • Royal Bank of Canada held 50 shares of First Trust Nasdaq Pharmaceuticals ETF worth $2K as of Q1 2026.
  • First Trust Nasdaq Pharmaceuticals ETF was a new Royal Bank of Canada position in Q1 2026.
  • First Trust Nasdaq Pharmaceuticals ETF made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6699 holding.
  • Royal Bank of Canada first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2016 and has held it in 23 quarters since.
  • Royal Bank of Canada's First Trust Nasdaq Pharmaceuticals ETF position peaked at $1.02M in Q3 2022.
  • 32 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.